Company Filing History:
Years Active: 2024-2025
Title: Innovations by Stephen D. Hauschka
Introduction
Stephen D. Hauschka is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the area of muscular dystrophy treatment. With a total of two patents to his name, his work is recognized for its potential impact on health and medicine.
Latest Patents
Hauschka's latest patents focus on micro-dystrophins and related methods of use. These patents provide nucleotide sequences that include a micro-dystrophin gene, which may be operatively linked to a regulatory cassette. The methods outlined in these patents aim to treat subjects who have, or are at risk of developing, muscular dystrophy, sarcopenia, heart disease, or cachexia. The pharmaceutical compositions described include the micro-dystrophin gene and a delivery vehicle, which can be administered to subjects, including those with Duchenne muscular dystrophy or Becker muscular dystrophy.
Career Highlights
Stephen D. Hauschka is affiliated with the University of Washington, where he continues to advance his research and innovations. His work is characterized by a commitment to improving therapeutic options for patients suffering from debilitating conditions.
Collaborations
Hauschka has collaborated with notable colleagues such as Jeffrey S. Chamberlain and Julian Ramos, contributing to a rich environment of innovation and research.
Conclusion
Stephen D. Hauschka's contributions to the field of biotechnology, particularly through his patents on micro-dystrophins, highlight his role as a significant inventor in the medical research community. His work promises to enhance treatment options for various muscular disorders.